Morvan's syndrome associated with voltage-gated K+ channel antibodies.
about
Continuous muscle activity, Morvan's syndrome and limbic encephalitis: ionic or non ionic disorders?Autoimmune encephalitis in psychiatric institutions: current perspectivesPotassium channel antibodies in two patients with reversible limbic encephalitisPotassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitisVoltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease.Autoimmune epilepsy: clinical characteristics and response to immunotherapyAutoimmune channelopathies of the nervous systemThe evaluation of rapidly progressive dementia.Autoimmune channelopathies.Autoimmune and paraneoplastic channelopathies.The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases.Neural antigen-specific autoimmune disorders.The recognition and treatment of autoimmune epilepsy in children.Paraneoplastic nerve hyperexcitability.Isaacs syndrome: A review.Differences in epileptic symptoms depending on the type of autoimmune-mediated limbic encephalitis.Clinical utility of seropositive voltage-gated potassium channel-complex antibody.The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis.Neuronal autoantibodies in epilepsy patients with peri-ictal autonomic findings.Delayed LGI1 seropositivity in voltage-gated potassium channel (VGKC)-complex antibody limbic encephalitis.The clinical spectrum of Caspr2 antibody-associated disease.Morvan syndrome following B-cell lymphoma.Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability.Cramp-fasciculation syndrome in patients with and without neural autoantibodies.Course and outcome of a voltage-gated potassium channel antibody negative Morvan's syndrome.Clinical-pathologic correlations in voltage-gated Kv1 potassium channel complex-subtyped autoimmune painful polyneuropathy.
P2860
Q27025073-7FDF2467-C07C-4DE2-8004-2346B078365DQ28079666-3D580F7B-DD94-4BBB-9BBC-7BF5E9394F23Q28206692-F7763445-9E98-4EED-A0E3-1655D1AB40B4Q28244864-5605AEB5-66CD-442E-B33A-C501792C337CQ33375581-B0B6DA50-28EB-4482-8B58-792FA7BC4BCFQ34263857-262062CC-17D8-446D-8F9C-B5FB49917A10Q35151881-EC1091A7-766F-4158-8CE8-B114D43BD9CCQ35974573-B1EF17C3-E858-4628-9D4A-E20BBC4974C3Q36577209-2CF19E0E-D94F-410C-9EFE-3D88AB34E583Q36774744-2E7F2585-F42F-444B-8E96-07293A1AB313Q37706192-600528D6-AB93-4988-8D07-94F4AD9785DBQ38020960-3CB829E5-F10D-4362-815C-F4DDC4D47ECAQ38284599-460E557A-4D70-45D5-B0A6-DD715DD581A6Q38319391-6E209601-D118-4998-AEC3-BC9B6A947F2AQ38367371-BAE6E30A-0270-4354-BEC7-FA0CB6A543A3Q38545106-D3FF4640-8597-4C0E-B917-67DD165C4D07Q39009676-9730537E-06B9-47F5-9F43-C890A27C0306Q39247906-14BE6120-7F2F-47EE-8D4E-523A8987D6E6Q40124475-A30D4B5B-9F03-4EE1-928B-B315B70F1792Q41172251-D45261B7-C162-4C10-A078-891ADD6E43DAQ42385999-A4F32987-B165-4181-B37A-743D1949A5E2Q43181565-28C1C158-D0C6-4AD4-9A45-896F70647092Q44195744-EF769B8E-452E-4E4E-A6E6-96957EB09734Q44300420-1B080109-FC8A-4D91-B51D-32F6670E18E8Q46101381-684E035A-BC06-4AAC-B49C-E771F92D8DD5Q51578956-3C32D1AA-FE76-417C-BAE9-EEFC3FA2F9AD
P2860
Morvan's syndrome associated with voltage-gated K+ channel antibodies.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Morvan's syndrome associated with voltage-gated K+ channel antibodies.
@ast
Morvan's syndrome associated with voltage-gated K+ channel antibodies.
@en
type
label
Morvan's syndrome associated with voltage-gated K+ channel antibodies.
@ast
Morvan's syndrome associated with voltage-gated K+ channel antibodies.
@en
prefLabel
Morvan's syndrome associated with voltage-gated K+ channel antibodies.
@ast
Morvan's syndrome associated with voltage-gated K+ channel antibodies.
@en
P2093
P356
P1433
P1476
Morvan's syndrome associated with voltage-gated K+ channel antibodies.
@en
P2093
P304
P356
10.1212/WNL.54.3.771
P407
P577
2000-02-01T00:00:00Z